The present study was designed to determine whether bradykinin induces endothelium-dependent hyperpolarization of vascular smooth muscle in human coronary arteries, and if so, to define the contribution of this hyperpolarization to endothelium-dependent relaxations. The membrane potential of arterial smooth muscle cells (measured by glass microelectrodes) and changes in isometric force were recorded in tissues from six patients undergoing heart transplantation. In the presence of indomethacin and NG-nitro-L-arginine (NLA), the membrane potential was -48.3±0.6 and -46.9±0.6 mV, in preparations with and without endothelium, respectively, and was not affected by treatment with perindoprilat, an angiotensin-converting enzyme inhibitor. In the presence of both indomethacin and NLA, bradykinin evoked transient and concentration-dependent hyperpolarizations only in tissues with endothelium, which were augmented by perindoprilat and mimicked by the calcium ionophore A23187. Glibenclamide did not inhibit membrane hyperpolarization to bradykinin. In rings contracted with prostaglandin F2,, the cumulative addition of bradykinin caused a concentration-dependent relaxation during contractions evoked by prostaglandin F2, which was not abolished by NLA and indomethacin. The present findings demonstrate the occurrence of endothelium-dependent hyperpolarization, and its contribution to endothelium-dependent relaxations, in the human coronary artery. (J. Clin. Invest. 1993. 92:2867-2871 
Introduction
Furchgott and Zawadzki (1) demonstrated the obligatory role of the endothelium in the relaxation of isolated arteries to acetylcholine, an observation that has been extended to numerous neurohumoral mediators in a variety ofblood vessels from different animal species (see references 2 and 3). Endotheliumdependent relaxations have been demonstrated in human coronary arteries (4, 5) . Endothelium-derived relaxing factor (EDRF,' identified as nitric oxide [6] [7] [8] ) plays a major role in endothelium-dependent relaxations. In addition, in animal blood vessels, endothelium-derived hyperpolarizing factor (EDHF) (9) (10) (11) (12) , an unidentified diffusible substance ( 11, 13, 14) distinct from nitric oxide ( 10, 15, 16) , contributes to endothelium-dependent relaxations by opening K+ channels in the underlying vascular smooth muscle (17) (18) (19) (20) (21) . The endothelium-dependent relaxations of isolated human coronary arteries are, in part, resistant to inhibitors of cyclooxygenase and nitric oxide synthase, which implies that an endothelial mediator other than prostacyclin and nitric oxide is involved (22) . The present study was designed to determine whether or not endothelium-dependent hyperpolarization occurs in the human coronary artery, and ifso, whether or not it contributes to endothelium-dependent relaxations.
Methods
Solutions and drugs. The tissues were incubated in modified KrebsRinger bicarbonate solution with the following composition (mM): 118.3, NaCl 4.7, KCI 2.5, CaC12 1.2, MgSO4 1.2, KH2PO4 25.0, NaHCO3 0.026 edetate calcium disodium (CaEDTA), and 1 1.1 glucose (control solution). High potassium solution (K+ 60 mM) was prepared by isotonic substitution of NaCl by KCl. Solutions were aerated with a 95% 02 and 5% CO2 gas mixture. The following drugs were used: bradykinin, the calcium ionophore A23 187, glibenclamide, indomethacin, prostaglandin F2<,, (Sigma Immunochemicals, St. Louis, MO), lemakalim (Beecham, Brentford, United Kingdom), N0-nitro L-arginine (Aldrich Chemical Co., Milwaukee, WI), and perindoprilat (Servier, Neuilly, France). Stock solutions were prepared in distilled water except for glibenclamide (prepared in ethanol), A23 187 and lemakalim (dissolved in dimethylsulfoxide), and indomethacin (dissolved in water and an equal molar concentration of Na2CO3 with sonication). Preliminary experiments indicated that none of the solvents used produced detectable changes in membrane potential or isometric force at the concentrations used (data not shown).
Coronary arteries. Epicardial coronary arteries were obtained from the excised hearts of six male cardiac transplant patients ( 15 mo-68 yr old). The hearts were classified as surgical specimens, and their use was exempted by the institutional review board from required patient consent. Drug treatment during the 2 wk before the transplant operations included furosemide (six patients), digoxin (four patients), captopril (three patients), and dobutamine/dopamine (three patients). All patients were treated with immunosuppressive drugs (methylprednisolone, cyclosporine, and azathioprine) several hours before the operation. The coronary arteries were isolated 3-5 min after the removal of the heart from the chest and placed in cold (4°C) control solution. Approximately 15 min later, the surrounding tissues were removed under a binocular microscope, and only arteries with a luminal opening devoid of visible atherosclerotic lesions were used. The blood vessels for electrophysiological studies (external diameter = 1.0-1.5 mm) and for organ chamber experiments (external diameter = 2 mm) were cut into rings (3-4 mm in length). In some rings, the endothelium was removed mechanically by inserting the tips of a watchmaker's forceps or an insect pin into the lumen and gently rolling the preparation back and forth over tissue paper saturated with cold control solution Electrophysiological studies. Rings of coronary artery (3-4 mm long) were opened longitudinally and pinned down on the bottom of an organ chamber (volume = 1.5 ml) with the endothelial side upward. The tissues were superfused with control solution (370C) at constant flow (3 ml/min). After 90 min ofincubation, glass capillary microelectrodes filled with 3 M KC1 (tip resistance = 50-80 MR) were inserted into the arterial smooth muscle from the intimal side. All experiments were performed in the presence of indomethacin ( 10-5 M) and NG-nitro-L-arginine (l0-' M) to prevent the formation of vasoactive prostanoids and nitric oxide, respectively (23, 24) . The electrical signal was amplified by means of a recording amplifier (World Precision Instruments, New Haven, CT). The membrane potential was monitored continuously on an oscilloscope (model 5223; Tektronix Inc., Beaverton, OR) and recorded on a pen recorder (model TA550; Gould Inc., Recording Systems Division, Cleveland, OH). The following criteria were used to assess the validity of a successful impalement: a sudden negative shift in voltage followed by (a) a stable negative voltage for more than 2 min and (b) an instantaneous return to the previous voltage level on dislodgement of the microelectrode. At least four impalements of the same artery were made to assess the variability of the electrophysiological parameters, in the presence and in the absence of endothelium, respectively.
Organ chamber experiments. The rings were suspended between two stirrups in organ chambers (20 ml) filled with control solution (gassed with 95% 02-5% C02, pH 7.4, maintained at 370C). The experiments were performed in the presence of indomethacin ( 10 -5 M). One of the stirrups was anchored inside the organ chamber, and the other was connected to a force transducer (model FTC103; Grass Instrument Co., Cleveland, OH) to record changes in isometric tension. The rings were stretched to the optimal point of their length-active tension relationship (range = 4-6 g), as determined by the contractile response to 60 mM K+ at progressive levels of stretch.
Statistical analysis. The results are expressed as mean±SEM.; n represents the number of cells examined in electrophysiological study. A two-tailed Student's t test (for paired observations) was used to evaluate the statistical significance of differences between means. P < 0.05 was considered to be statistically significant.
Results
Electrophysiological studies. In the six coronary arteries studied for electrophysiological experiments, the membrane of the smooth muscle cells was electrically quiescent and did not exhibit rhythmic fluctuations in membrane potential. The resting membrane potentials averaged -48.7±0.6 mV (n = 28) and -46.9±0.6 mV (n = 21 ) in preparations with and without endothelium, respectively (Table I) . Perindoprilat (10-6 M; inhibitor of converting enzyme) did not alter the resting membrane potential significantly (Table I) . Bradykinin caused transient hyperpolarization of cell membranes in tissues with, but not in those without endothelium (in coronary arteries from five out of six patients) (Fig.  1) . The response of human coronary arteries to bradykinin declined with repeated application. Reproducibility of membrane hyperpolarization induced by a given concentration of bradykinin (e.g., 10' M for 1 min) could be achieved by allowing a 30-min interval between exposure ofthe tissues to the peptide (data not shown). Incubation with perindoprilat (10-6 M) potentiated the hyperpolarization to bradykinin (at 10' M, -2.5±1.8 and -9.0±2.1 mV, in the absence and presence of perindoprilat, respectively; n = 4, four individuals, P < 0.05). In the presence of perindoprilat, the concentrationhyperpolarization curves to bradykinin (10-1-10-7 M) were comparable in the coronary arteries of five out of six patients (Fig. 2) . In tissues from three patients (cases D, E, and F), membrane hyperpolarizations were observed in response to the activator of ATP-sensitive potassium channels lemakalim (10-6 M; Fig. 3 A) , both in tissues with and without endothelium. Glibenclamide (3 X 10 -6 M, an inhibitor of ATP-sensitive K+ channels) abolished the membrane hyperpolarizations in response to lemakalim (Fig. 3 A) . The membrane hyperpolarization induced by bradykinin was not inhibited by glibenclamide (Fig. 3 B) . The calcium ionophore A23187 ( 10-7_10-6 M) caused concentration-dependent membrane hyperpolarizations in tissues with endothelium, which were not attenuated by glibenclamide (Fig. 3 C) .
Organ chamber experiments. In rings of coronary arteries of three of the patients (cases B, F, and G), the cumulative addition of bradykinin caused a concentration-dependent recontrol A lemakalim, 10 laxation during contractions evoked by prostaglandin F2", (8 X 10-6 M; Fig. 4 ). In rings incubated with perindoprilat, N0-nitro-L-arginine did not abolish the relaxation to bradykinin (Fig. 4) . Relaxations were not observed in rings without endothelium.
Discussion
The aim of the present study was to investigate the membrane potential characteristics of vascular smooth muscle cells in the human coronary artery, to determine whether these parameters are influenced by the endothelium, and to assess whether or not electrophysiological changes in the vascular smooth muscle contribute at least in part to endothelium-dependent relaxations.
The present findings demonstrate that bradykinin causes endothelium-dependent hyperpolarization of vascular smooth muscle cells in the human coronary artery. A similar response has been documented repeatedly in animal blood vessels with bradykinin and other endothelial stimulants (10, 25, 26) , and has been attributed to the release of a diffusible substance, EDHF (9, 11, 14) . In the uterine artery of the guinea pig (27) and in small mesenteric arteries ofthe rat (20) , nitric oxide can cause membrane hyperpolarization. By contrast, nitric oxide evokes relaxations, but does not hyperpolarize smooth muscle cells in the arteries of several species (8, 9, 15, 16, 18) . Prostacyclin may also produce hyperpolarization of smooth muscle cell membranes in certain blood vessels (28) . In the present experiments with human coronary arteries, the release ofeither EDRF (nitric oxide) or prostaglandins induced by bradykinin (5, 22, 29) cannot account for the observed hyperpolarization, which was not affected by combined inhibition ofcyclooxygenase and nitric oxide synthase (23, 24) . A similar conclusion has been reached in coronary arteries of various species (19, 30, 31) . The effect of bradykinin is concentration dependent, and is mimicked by the calcium ionophore A23187 in tissues with endothelium, in agreement with earlier observations in animal arteries (19, 32) . This indicates that, as the activation of nitric oxide synthase and cyclooxygenase, the process leading to the release of EDHF depends on intracellular calcium mobilization (33) . Likewise, the production of EDHF is calcium-dependent and inhibited by calmodulin antagonists in canine and porcine coronary arteries (34, 35) . As in animal coronary arteries, the endothelium-dependent hyperpolarization evoked by bradykinin is potentiated by the converting enzyme inhibitor, perindoprilat (36) .
In human coronary arteries, unlike the rabbit cerebral artery (18, 37), endothelium-dependent hyperpolarizations were not inhibited by glibenclamide at a concentration that abolished the hyperpolarization to lemakalim. These observations suggest that the hyperpolarization to lemakalim. These observations suggest that the hyperpolarizations of human coronary smooth muscle induced by bradykinin and A23187 do not result from the opening of ATP-sensitive K+ channels. A similar conclusion has been reached in coronary arteries of other species (19, 31, 35) . In addition, these findings confirm that the hyperpolarization is not mediated by EDRF, since the hyperpolarization caused by exogenous nitric oxide in rat mesenteric arteries is prevented by glibenclamide (20) . The types ofpotassium channels involved in endothelium-dependent hyperpolarizations differ among blood vessels and/or species (18, 37).
The persistence in the present experiments ofendothelium- dependent relaxations to bradykinin in the presence of NG-nitro-L-arginine is consistent with the observation in epicardial human coronary arteries that the relaxation to substance P is not abolished by inhibitors of nitric oxide synthase (22) . Taken into conjunction with the electrophysiological studies, it suggests that hyperpolarization may, at least in part, contribute to endothelium-dependent relaxations of the human coronary artery.
In conclusion, the present study demonstrates that endothelium-dependent hyperpolarization occurs in human coronary arteries in response to bradykinin and the calcium ionophore A23 187. This effect does not result from opening ofATP-sensitive potassium channels. Since this endothelium-dependent hyperpolarization was present in coronary arteries from patients with different cardiac diseases, it may be a mechanism of importance for the regulation of the degree of contraction of vascular smooth muscle in healthy coronary arteries.
